125 related articles for article (PubMed ID: 33009490)
21.
Lee KH; Gowrishankar K; Street J; McGuire HM; Luciani F; Hughes B; Singh M; Clancy LE; Gottlieb DJ; Micklethwaite KP; Blyth E
Clin Transl Immunology; 2020; 9(10):e1200. PubMed ID: 33101678
[TBL] [Abstract][Full Text] [Related]
22. The utility of PRAME staining in identifying malignant transformation of melanocytic nevi.
Lohman ME; Steen AJ; Grekin RC; North JP
J Cutan Pathol; 2021 Jul; 48(7):856-862. PubMed ID: 33433032
[TBL] [Abstract][Full Text] [Related]
23. PRAME immunohistochemistry as an adjunct for diagnosis and histological margin assessment in lentigo maligna.
Gradecki SE; Valdes-Rodriguez R; Wick MR; Gru AA
Histopathology; 2021 Jun; 78(7):1000-1008. PubMed ID: 33280156
[TBL] [Abstract][Full Text] [Related]
24. Cancer Testis Antigens and Immunotherapy: Expression of PRAME Is Associated with Prognosis in Soft Tissue Sarcoma.
Albertsmeier M; Altendorf-Hofmann A; Lindner LH; Issels RD; Kampmann E; Dürr HR; Schubert-Fritschle G; Angele MK; Kirchner T; Jungbluth AA; Knösel T
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33287125
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological and Prognostic Significance of PRAME Overexpression in Human Cancer: A Meta-Analysis.
Li J; Yin J; Zhong J; Yang Z; Tang A; Li S
Biomed Res Int; 2020; 2020():8828579. PubMed ID: 33381588
[TBL] [Abstract][Full Text] [Related]
26. The many faces of solitary fibrous tumor; diversity of histological features, differential diagnosis and role of molecular studies and surrogate markers in avoiding misdiagnosis and predicting the behavior.
Tariq MU; Din NU; Abdul-Ghafar J; Park YK
Diagn Pathol; 2021 Apr; 16(1):32. PubMed ID: 33879215
[TBL] [Abstract][Full Text] [Related]
27. The Role of Immunotherapy in the Treatment of Rare Central Nervous System Tumors.
Rodriguez A; Kamiya-Matsuoka C; Majd NK
Curr Oncol; 2023 May; 30(6):5279-5298. PubMed ID: 37366884
[TBL] [Abstract][Full Text] [Related]
28. Transcriptomic insights into adenoid cystic carcinoma via RNA sequencing.
Tang YF; An PG; Gu BX; Yi S; Hu X; Wu WJ; Zhang J
Front Genet; 2023; 14():1144945. PubMed ID: 37152992
[No Abstract] [Full Text] [Related]
29. Extra-meningeal solitary fibrous tumor: an evolving entity with chameleonic morphological diversity, a hallmark molecular alteration and unresolved issues in risk stratification assessment.
Machado I; Giner F; Cruz J; Lavernia J; Marhuenda-Fluixa A; Claramunt R; López-Guerrero JA; Navarro S; Ferrandez A; Blázquez Bujeda Á; Ruiz-Sauri A; Llombart-Bosch A
Histol Histopathol; 2023 Oct; 38(10):1079-1097. PubMed ID: 36975173
[TBL] [Abstract][Full Text] [Related]
30. Branched Linkers for Site-Specific Fluorescent Labeling of Antibodies.
Sapozhnikova KA; Gulyak EL; Misyurin VA; Simonova MA; Ryabukhina EV; Alexeeva AV; Tikhonova NA; Lyzhko NA; Popova GP; Misyurin AV; Ustinov AV; Korshun VA; Alferova VA; Ryazantsev DY; Brylev VA
Molecules; 2023 Jan; 28(1):. PubMed ID: 36615611
[TBL] [Abstract][Full Text] [Related]
31. Magnetic resonance imaging features of a solitary fibrous tumor of the vulva: a case report.
Lin C; Yu X
J Int Med Res; 2022 Jul; 50(7):3000605221112201. PubMed ID: 35899898
[TBL] [Abstract][Full Text] [Related]
32. Kita-Kyushu Lung Cancer Antigen-1 (KK-LC-1): A Promising Cancer Testis Antigen.
Bai R; Yuan C
Aging Dis; 2022 Jul; 13(4):1267-1277. PubMed ID: 35855340
[TBL] [Abstract][Full Text] [Related]
33. Sensitive Immunofluorescent Detection of the PRAME Antigen Using a Practical Antibody Conjugation Approach.
Sapozhnikova KA; Misyurin VA; Ryazantsev DY; Kokin EA; Finashutina YP; Alexeeva AV; Ivanov IA; Kocharovskaya MV; Tikhonova NA; Popova GP; Alferova VA; Ustinov AV; Korshun VA; Brylev VA
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884647
[TBL] [Abstract][Full Text] [Related]
34. Solitary Fibrous Tumor: Integration of Clinical, Morphologic, Immunohistochemical and Molecular Findings in Risk Stratification and Classification May Better Predict Patient outcome.
Machado I; Nieto Morales MG; Cruz J; Lavernia J; Giner F; Navarro S; Ferrandez A; Llombart-Bosch A
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502329
[TBL] [Abstract][Full Text] [Related]
35. A Comprehensive Review on Solitary Fibrous Tumor: New Insights for New Horizons.
Martin-Broto J; Mondaza-Hernandez JL; Moura DS; Hindi N
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34200924
[TBL] [Abstract][Full Text] [Related]
36. RNA expression profiling reveals PRAME, a potential immunotherapy target, is frequently expressed in solitary fibrous tumors.
Wang WL; Gokgoz N; Samman B; Andrulis IL; Wunder JS; Demicco EG
Mod Pathol; 2021 May; 34(5):951-960. PubMed ID: 33009490
[TBL] [Abstract][Full Text] [Related]
37. Cancer-testis antigen expression in synovial sarcoma: NY-ESO-1, PRAME, MAGEA4, and MAGEA1.
Iura K; Maekawa A; Kohashi K; Ishii T; Bekki H; Otsuka H; Yamada Y; Yamamoto H; Harimaya K; Iwamoto Y; Oda Y
Hum Pathol; 2017 Mar; 61():130-139. PubMed ID: 27993576
[TBL] [Abstract][Full Text] [Related]
38. Expanding the spectrum of malignant progression in solitary fibrous tumors: a study of 8 cases with a discrete anaplastic component--is this dedifferentiated SFT?
Mosquera JM; Fletcher CD
Am J Surg Pathol; 2009 Sep; 33(9):1314-21. PubMed ID: 19718788
[TBL] [Abstract][Full Text] [Related]
39. TERT promoter mutations and prognosis in solitary fibrous tumor.
Bahrami A; Lee S; Schaefer IM; Boland JM; Patton KT; Pounds S; Fletcher CD
Mod Pathol; 2016 Dec; 29(12):1511-1522. PubMed ID: 27562490
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
